Identification of Anti-Long Chain Saturated Fatty Acid IgG Antibodies in Serum of Patients with Type 2 Diabetes

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Nicholas, Dequina A ^a   Salto, Lorena M ^a   Boston, Ava M ^a   Kim, Nan Sun ^a   Larios, Marco ^a   Beeson, W Lawrence ^a,b   Firek, Anthony F ^c   Casiano, Carlos A ^a   Langridge, William H R ^a   Cordero MacIntyre, Zaida ^a,b,d   De Leon, Marino ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d WHITTIER COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1BETA; LONG CHAIN SATURATED FATTY ACID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; FATTY ACID; IMMUNOGLOBULIN G; PALMITIC ACID;

ADULT; ARTICLE; COHORT ANALYSIS; CYTOKINE RELEASE; DIABETES EDUCATION; DIABETIC PATIENT; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AGED; ANTIBODY SPECIFICITY; BLOOD; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ANTIBODY SPECIFICITY; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PALMITIC ACID;

EID: 84948440857     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/196297     Document Type: Article

References (36)

1. S. Santos, A. Oliveira, and C. Lopes, "Systematic review of saturated fatty acids on infammation and circulating levels of adipokines," Nutrition Research, vol. 33, no. 9, pp. 687-695, 2013.
2. A. Muñoz and M. Costa, "Nutritionally mediated oxidative stress and infammation," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 610950, 11 pages, 2013.
3. A. R. Martins, R. T. Nachbar, R. Gorjao et al., "Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function," Lipids in Health and Disease, vol. 11, article 30, 2012.
4. G. Cascio, G. Schiera, and I. di Liegro, "Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases," Current Diabetes Reviews, vol. 8, no. 1, pp. 2-17, 2012.
5. N. Esser, S. Legrand-Poels, J. Piette, A. J. Scheen, and N. Paquot, "Infammation as a link between obesity, metabolic syndrome and type 2 diabetes," Diabetes Research and Clinical Practice, vol. 105, no. 2, pp. 141-150, 2014.
6. E. Oliver, F. McGillicuddy, C. Phillips, S. Toomey, and H. M. Roche, "The role of infammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic efects of long-chain n-3 PUFA," The Proceedings of the Nutrition Society, vol. 69, no. 2, pp. 232-243, 2010.
7. B. X. W. Wong, R. A. Kyle, P. C. Myhill et al., "Dyslipidemic diabetic serum increases lipid accumulation and expression of stearoyl-CoA desaturase in human macrophages," Lipids, vol. 46, no. 10, pp. 931-941, 2011.
8. E. K. Grishman, P. C. White, and R. C. Savani, "Toll-like receptors, the NLRP3 infammasome, and interleukin-1beta in the development and progression of type 1 diabetes," Pediatric Research, vol. 71, no. 6, pp. 626-632, 2012.
9. T. Kawai and S. Akira, "The role of pattern-recognition receptors in innate immunity: update on toll-like receptors," Nature Immunology, vol. 11, no. 5, pp. 373-384, 2010.
10. C. A. Dinarello, M. Y. Donath, and T. Mandrup-Poulsen, "Role of IL-1β in type 2 diabetes," Current Opinion in Endocrinology, Diabetes and Obesity, vol. 17, no. 4, pp. 314-321, 2010.
11. J. A. Ehses, G. Lacraz, M.-H. Giroix et al., "IL-1 antagonism reduces hyperglycemia and tissue infammation in the type 2 diabetic GK rat," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 13998-14003, 2009.
12. X. Luo, Y. Yang, T. Shen et al., "Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and infammation through repressing NLRC4 infammasome activation in HepG2 cells," Nutrition & Metabolism, vol. 9, article 34, 2012.
13. S. Sam and T. Mazzone, "Adipose tissue changes in obesity and the impact on metabolic function," Translational Research: The Journal of Laboratory and Clinical Medicine, vol. 164, no. 4, pp. 284-292, 2014.
14. J. M. Olefsky and C. K. Glass, "Macrophages, infammation, and insulin resistance," Annual Review of Physiology, vol. 72, pp. 219-246, 2009.
15. S. Winer and D. A. Winer, "The adaptive immune system as a fundamental regulator of adipose tissue infammation and insulin resistance," Immunology and Cell Biology, vol. 90, no. 8, pp. 755-762, 2012.
16. C. Dufaut, J. Galitzky, M. Lafontan, and A. Bouloumié, "Unexpected trafcking of immune cells within the adipose tissue during the onset of obesity," Biochemical and Biophysical Research Communications, vol. 384, no. 4, pp. 482-485, 2009.
17. D. A. Winer, S. Winer, M. H. Y. Chng, L. Shen, and E. G. Engle-man, "B Lymphocytes in obesity-related adipose tissue infam-mation and insulin resistance," Cellular and Molecular Life Sciences, vol. 71, no. 6, pp. 1033-1043, 2014.
18. D. A. Winer, S. Winer, L. Shen et al., "B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies," Nature Medicine, vol. 17, no. 5, pp. 610-617, 2011.
19. A. Horváth and A. Bíró, "Anti-cholesterol antibodies in human sera," Autoimmunity Reviews, vol. 2, no. 5, pp. 272-277, 2003.
20. A. Amara, C. Chaugier, and M. Gefard, "Autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients," AIDS, vol. 8, no. 5, pp. 711-713, 1994.
21. A. Amara, C. Chaugier, J.-M. Ragnaud, and M. Gefard, "Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients," Clinical and Experimental Immunology, vol. 96, no. 3, pp. 379-383, 1994.
22. A. I. Boullerne, K. G. Petry, and M. Gefard, "Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis," Journal of Neuroimmunology, vol. 65, no. 1, pp. 75-81, 1996.
23. G. Wheeler, S. B. Montgomery, L. Beeson et al., "En Balance: the efects of Spanish diabetes education on physical activity changes and diabetes control," The Diabetes Educator, vol. 38, no. 5, pp. 723-732, 2012.
24. R. M. Peterson, L. Beeson, E. Shulz et al., "Impacting obesity and glycemic control using a culturally-sensitive diabetes education program in Hispanic patients with type 2 diabetes," International Journal of Body Composition Research, vol. 8, no. 3, pp. 85-94, 2010.
25. S. Metghalchi, M. Rivera, L. Beeson et al., "Improved clinical outcomes using a culturally sensitive diabetes education program in a hispanic population," Diabetes Educator, vol. 34, no. 4, pp. 698-706, 2008.
26. L. M. Salto, Z. Cordero-MacIntyre, L. Beeson, E. Schulz, A. Firek, and M. de Leon, "En balance participants decrease dietary fat and cholesterol intake as part of a culturally sensitive hispanic diabetes education program," The Diabetes Educator, vol. 37, no. 2, pp. 239-253, 2011.
27. E. Ojo, L. Beeson, E. Shulz et al., "Efect of the EnBalance, a culturally and language-sensitive diabetes education program, on dietary changes and plasma lipid profle in Hispanic diabetics," International Journal of Body Composition Research, vol. 8, supplement, pp. S69-S76, 2010.
28. I. Chukwueke, A. Firek, L. Beeson et al., "The En Balance Spanish diabetes education program improves apolipoproteins, serum glucose and body composition in hispanic diabetics," Ethnicity & Disease, vol. 22, no. 2, pp. 215-220, 2012.
29. J. C. Bishop, F. D. J. Dunstan, B. J. Nix, T. M. Reynolds, and A. Swif, "All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median," American Journal of Human Genetics, vol. 52, no. 2, pp. 425-430, 1993.
30. P. Yaqoob, "Fatty acids and the immune system: from basic science to clinical applications," Proceedings of the Nutrition Society, vol. 63, no. 1, pp. 89-104, 2004.
31. J. B. Dowd and A. E. Aiello, "Socioeconomic diferentials in immune response," Epidemiology, vol. 20, no. 6, pp. 902-908, 2009.
32. P. A. Sheridan, H. A. Paich, J. Handy et al., "Obesity is associated with impaired immune response to infuenza vaccination in humans," International Journal of Obesity, vol. 36, no. 8, pp. 1072-1077, 2012.
33. K. M. Young, C. M. Gray, and L.-G. Bekker, "Is obesity a risk factor for vaccine non-responsiveness?" PLoS ONE, vol. 8, no. 12, Article ID e82779, 2013.
34. H. A. Paich, P. A. Sheridan, J. Handy et al., "Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 infuenza a virus," Obesity, vol. 21, no. 11, pp. 2377-2386, 2013.
35. C. Lagathu, L. Yvan-Charvet, J.-P. Bastard et al., "Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes," Diabetologia, vol. 49, no. 9, pp. 2162-2173, 2006.
36. I. C. M. MacLennan, A. Gulbranson-Judge, K.-M. Toellner et al., "The changing preference of T and B cells for partners as T-dependent antibody responses develop," Immunological Reviews, vol. 156, pp. 53-66, 1997.